Abstract
Patients with Alzheimer's disease (AD), Parkinson's disease (PD), traumatic brain injury (TBI), stroke, and postoperative neurocognitive disorder (POND) are commonly faced with neurocognitive disorders with limited therapeutic options. Some non-coding ribonucleic acids (ncRNAs) are involved in the development of various brain cognitive disorders. Circular RNAs (circRNAs), a typical group of ncRNAs, can function as competitive endogenous RNAs (ceRNAs) to dysregulate shared microRNAs (miRNAs) at post-transcription level, inhibiting regulation of miRNAs on their targeted messenger RNAs (mRNAs). circRNAs are abundant in central nervous system (CNS) diseases and cause brain disorders, but the exact roles of circRNAs are unclear. The crosstalk between circRNA, miRNA, and mRNA plays an important role in the pathogenesis of these neurocognitive dysfunction diseases and abnormal conditions including AD, PD, stroke, TBI, and POND. In this review, we summarized the participation of circRNA in neuroglial damage and inflammation. Finally, we aimed to highlight the regulatory mechanisms of circRNA–miRNA–mRNA networks in the development of various brain cognitive disorders and provide new insights into the therapeutics of these diseases.
Introduction
Microribonucleic acids (miRNAs) are small, non-coding, single-stranded linear RNAs spanning an average of 22 nucleotides in length. miRNAs can bind to the 3′ untranslated region (UTR) of messenger RNAs (mRNAs) via miRNA recognition elements (MRE) of target genes, which are presented in repression or degradation at the posttranscriptional levels, resulting in the dysregulation of the expression of target proteins (Salmena et al., 2011; Salim et al., 2022). Unlike classical linear RNAs, circular RNAs (circRNAs) are a novel group of evolutionarily conserved non-coding RNAs (ncRNAs) that form covalently closed continuous loop structures without 5' caps or 3' Poly A tails and act as sponges of miRNAs (Kristensen et al., 2019; Chen et al., 2022). Here, a total of 262,782 circRNAs have been presented in CIRCpedia v2 embracing over 180 RNA-seq data sets that cross six different species (Dong et al., 2018). Meanwhile, the crosstalk mechanism between circRNA, miRNA, and mRNA is not clearly understood.
As mentioned above, most genomes are presented in a miRNA-dependent repression manner and are densely covered in MREs like the letters of an “RNA language,” which function as the entire mRNA dimension by identifying competitive endogenous miRNA (ceRNA) networks in the ncRNA pool (Salmena et al., 2011; Hansen et al., 2013). The ceRNA of long ncRNA in miRNA regulation is validated (Salmena et al., 2011). Some circRNAs could function as molecular sponges for other RNA transcripts through their miRNA binding sites by ceRNA (Hansen et al., 2013). circRNA functions as miRNA sponge to dysregulate stability, transcription, and translation of mRNAs (Figure 1), which are the target genes of miRNAs, in complicated mechanisms (Hansen et al., 2013; Yesharim et al., 2021; D'Anca et al., 2022).
Figure 1

Circular RNAs (CircRNAs) act as the sponges of microRNAs (miRNAs) in neuroglial damage. Main circRNAs can act as miRNA sponges, resulting in the inhibition of miRNA on its target genes and/or proteins, and function as important roles in neuronal damage. Some circRNAs derived from extracellular vesicles (EVs) in astrocytes are beneficial for the attenuation of neurological disorders.
A lot of studies indicate that the crosstalk between circRNAs, miRNAs, and mRNA can participate in many pathophysiological processes in the development of cerebral diseases (or abnormal conditions), such as Alzheimer's disease (AD) (Lu et al., 2019; Li et al., 2022), Parkinson's disease (PD) (Wang et al., 2021; Liu et al., 2022), traumatic brain injury (TBI) (Huang X. J. et al., 2022; Zheng et al., 2022), stroke (Dai et al., 2021; Xu T. et al., 2022), and postoperative neurocognitive disorder (POND) (He et al., 2021; Wu et al., 2021; Zhang M. X. et al., 2022). However, they have failed to manage the aforementioned brain cognitive disorders with effective therapeutics and to uncover largely unknown underlying mechanisms.
In this review, we discussed the effects of circRNAs on various brain neurocognitive disorders as mentioned above. We also found a network of circRNA–miRNA–mRNA for the potential treatment or therapeutics of the aforementioned neurocognitive impaired diseases or conditions.
CircRNA–miRNA–mRNA networks in brain cognitive disorders
Alzheimer's disease
Alzheimer's disease, the most common cause of dementia, is a rising global health issue with tremendous implications. A crucial characteristic of AD is an aberrant accumulation of β-amyloid (Aβ) peptides in the brain, in terms of enhanced cleavage of Aβ precursor protein (APP) by the rate-limiting β-site APP-cleaving enzyme 1 (BACE1) (Shi et al., 2017). The circRNA cerebellar degeneration-related protein 1 antisense (CDR1as, also known as ciRS-7), a gigantic molecule, functions as a miR-7 sponge or inhibitor (Kumar et al., 2017; Li et al., 2019). However, ciRS-7 expression inhibits the translation of nuclear factor kappa B (NF-κB) and induces its cytoplasmic localization, derepressing the expression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1), which enhances the degradation of APP and BACE1 so as to be available in neuroprotection (Shi et al., 2017). The downregulation of ciRS-7 upregulates miR-7 and lowers the expression of ubiquitin-conjugating enzyme E2A (UBE2A, a location in chr Xq24), which coordinates the clearance of Aβ via proteolysis and contributes to the accumulation of Aβ and the formation of senile plaque deposits (Zhao et al., 2016). However, the trend toward change of consistency relationship between CDR1as/ciRS-7 and miR-7 is still controversial. In addition, in terms of sponging or inhibition of miR-7, ciRS-7 may prevent miR-7 from degradation (Kleaveland et al., 2018).
Serum circHDAC9 was decreased in patients with AD and individuals with mild cognitive impairment. circHDAC9 acts as a miR-138 sponge, decreasing miR-138 expression and reversing the suppression of silent information regulator 1 (Sirt1) and excess production of Aβ in AD (Lu et al., 2019).
Circ_0000950 sponging miR-103 increases the expression of prostaglandin-endoperoxide synthase 2 (PTGS2) and elevates the levels of inflammatory cytokines [interleukin-1β (IL-1β), IL-6, and tumor necrosis factor α (TNF-α)] to inhibit neurite outgrowth and promote neuron apoptosis in AD (Yang et al., 2019). The downregulation of circ_0001588 upregulates miR-211-5p and induces the Sirt1/nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway to prevent oxidative stress in AD (Zhu et al., 2020). CircAXL decreases miR-328 to upregulate the expression of BACE1 in AD (Li et al., 2022). Circ_0003611 downregulates miR-885-5p to aggravate Aβ-induced neuronal injury in AD (Pan et al., 2022). Circ_0005835 promotes the development of AD via regulating miR-576-3p expression (Xu X. et al., 2022).
The networks of circRNA–miRNA–mRNA are involved in mitogen-activated protein kinase (MAPK), mammalian target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and Wnt signaling pathways in the pathogenesis of AD (Li Y. et al., 2020). Certainly, in the presence of RNA-seq and prediction tools for circRNA bioinformatic analysis, the circRNA–miRNA–mRNA network will indicate one more potential role of epigenetic control over the expression of pathogenic genes in the human central nervous system (CNS) in the development and therapeutic treatment of sporadic AD.
Parkinson's disease
Parkinson's disease, characterized by motor and non-motor symptoms, is also a neurodegenerative disorder. A growing body of research in recent decades has denoted that cognitive decline is a common non-motor symptom of PD (Hall and Lewis, 2019; Leng et al., 2020). With the development of potentially effective treatment, useful biomarkers (such as α-synuclein and some possible circRNAs) of PD may provide early diagnosis, therapeutic monitoring, and prognosis (Hosaka et al., 2019; Liu et al., 2022). The RNA-binding protein FUS acts as a new regulator of circRNA production in motor neurons in mice (Errichelli et al., 2017; D'Anca et al., 2022).
In PD, the neuroprotective role of miR-7 is induced through the alleviation of the suppression of NF-κB by lowering the expression of RelA (a component of NF-κB) due to dopaminergic neurotoxicity (Choi et al., 2014). In addition, miR-7 can target and downregulate α-synuclein, protecting neurons from oxidative stress (Junn et al., 2009; Zhu et al., 2021). circzip-2 sponging miR-60 decreases the expression of protein α-synuclein in the Caenorhabditis elegans model of PD (Kumar et al., 2018). In a mouse model, the circ_0003292/miR-132/Nr4a2 network may be involved in the molecular mechanism of PD (Jia et al., 2020).
In in vivo and in vitro studies, circRNA DLGAP4 (circDLGAP4) exerts a promotion in viability, a reduction in apoptosis, a decline in mitochondrial damage, and an enhancement in autophagy via modulating the miR-134-5p/CREB pathway in PD (Feng et al., 2020). circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK/mTOR pathway in PD (Wang et al., 2021). circPank1 promotes dopaminergic neuron neurodegeneration through the modulation of the miR-7a-5p/α-syn pathway in PD (Liu et al., 2022). Moreover, circ_0004381 functions as a sponge of miR-185-5p to affect RAC1 expression, contributing to MPP(+)-triggered neuron injury in a cellular model of PD in SK-N-SH cells (Zhang et al., 2022).
Traumatic brain injury
Due to the higher rates of morbidity and mortality, TBI with unclear mechanisms is a serious problem for individuals and society. In the hippocampus of TBI rats, the expressions of circ_006508 and circ_010705 are upregulated, while the expressions of circ_001167 and circ_001168 are downregulated (Xie et al., 2018). In C57BL/6 mice subjected to TBI, increased circRNA chr8_87859283-87904548 blocks the restoration of neurological function after TBI by the chr8_87859283-87904548/mmu-let-7a-5p/CXCR2 axis (Chen et al., 2019). According to the profile of exosomes isolated from the cerebral extracellular space after TBI, 231 significantly dysregulated circRNAs (155 upregulated and 76 downregulated) were on presentation. Pathways of neuronal growth and repair, development, glutamatergic synapse signal transmission, and cyclic guanosine monophosphate–protein kinase G were predicted according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses (Zhao et al., 2018).
Circ_0020269 (circHtra1) was significantly upregulated in the brain with TBI. CircHtra1 serves as a miR-3960 sponge, upregulates the levels of GRB10, inhibits cell proliferation, and promotes neuronal apoptosis and NK cell infiltration after TBI (Zheng et al., 2022). After the validation of the polymerase chain reaction (PCR) of 10 circRNAs, circ_009194 was the most upregulated in the hippocampus after TBI. Mechanistically, circ_009194 functions as a sponge for miR-145-3p to regulate Sp1-mediated voltage-gated sodium channel (Nav1.3) in neurological outcomes in TBI (Huang X. J. et al., 2022). circ_010705 (circLrp1b) is significantly upregulated in the brain with TBI induced by controlled cortical impact (CCI). Upregulated circLrp1b as a sponge of miR-27a-3p increases the expression of Dram2 and promotes neurologic impairment, autophagy, and inflammation after TBI (Li H. et al., 2020).
Stroke
Cerebrovascular disease with complicated mechanisms is one of the top three causes of disability-adjusted life-years (DALYs) globally (Collaborators GDH, 2017). The expression of circRNA circ_008018, circ_015350, and circ_016128 was upregulated, while the expression of circ_011137, circ_001729, and circ_006696 was downregulated. Each of these validated circRNAs may have more than 60 binding sites for miRNAs, which may be involved in the predicted pathways of MAPK, the cell cycle, and the regulation of the actin cytoskeleton (Mehta et al., 2017). In ischemic brain stroke, three (1,027 in total) circRNAs (circ_40001, circ_013120, and circ_40806) with the corresponding pathway of Rap1 signaling and Hippo signaling (according to the KEGG and GO analysis) regulate cell survival, death, and recovery through networks of circRNA–miRNA-target genes (Liu et al., 2017). However, the mechanism of circRNAs in the development of stroke remains largely unknown.
Expressions of circRNA Hectd1 (circHectd1) in ischemic stroke tissues from transient middle cerebral artery occlusion (tMCAO) mice and in plasma samples from patients with acute ischemic stroke (AIS) are significantly increased. In tMCAO mice, the knockdown of circHectd1 can significantly decrease cerebral infarct size, neuronal deficits, and astrocyte activation, though miR-142 targets TCDD inducible poly[ADP-ribose] polymerase (TIPARP) and inhibits the astrocyte activation via macroautophagy/autophagy (Han et al., 2018). The levels of circHectd1 are increased in patients with AIS, predicting a much higher risk of AIS recurrence with an area under the curve (AUC) of 0.694 (95% confidence interval (CI): 0.586–0.801) (Peng et al., 2019). The downregulation of circHectd1 induces neuroprotection against ischemic stroke through the miR-133b/TRAF3 pathway (Dai et al., 2021). CircHectd1 regulates ischemic stroke injury via mechanisms involving the regulation of the let-7c-5p/ROCK1 axis (Guo et al., 2022).
Injection of circDLGAP4 can significantly attenuate neurological deficits, infarct size, and blood–brain barrier damage via circDLGAP4/miR-143/Hectd1 axes in tMCAO in a mouse stroke model (Bai et al., 2018). Bioinformatic analysis indicates that the upregulation of circ_015947 could enhance the expression of the predicted sponging miRNAs (miR-188-3p, miR-329-5p, miR-3057-3p, miR-5098, and miR-683), which are involved in apoptosis, metabolism, and the immune-related pathways in the pathogenesis of stroke (Lin et al., 2016). Circ_0025984 ameliorates ischemic stroke injury and protects astrocytes via the miR-143-3p/TET1/ORP150 pathway (Zhou et al., 2021). Overexpression of circ_0000831 is sufficient to inhibit neuroinflammation and vertigo in cerebral ischemia through a miR-16-5p-dependent mechanism (Huang et al., 2022). circSKA3, in an area under the ROC curve of 0.614 (95% CI: 0.546–0.680) in predicting clinical outcomes of patients with AIS, acts as a sponge of miR-6796-5p by regulating the expression of matrix metalloproteinase 9 (Xu T. et al., 2022). Hypoxic pretreated adipose-derived stem cell (ADSC) exosome improves cognitive function by decreasing neuronal damage and shifting microglia from an M1 to M2 phenotype in the hippocampus of AIS via circRps5/miR-124-3p/SIRT7 axes (Yang H. et al., 2022). CircUSP36 attenuates ischemic stroke injury through the miR-139-3p/SMAD3/Bcl2 signal axis (Yang J. et al., 2022). The ratio of serum circRNA-284 to miR-221 may serve as a diagnostic biomarker of carotid plaque rupture and stroke with an AUC of 0.98 (95% CI: 0.96–1.00) (Bazan et al., 2017). As mentioned above, several circRNAs function as both potential therapeutics and biomarkers for ischemic stroke.
Postoperative neurocognitive disorder
During postoperative recovery, patients suffer from neurocognitive disorders. Preclinical neurocognitive disorders before anesthesia and surgery, the early onset of postoperative delirium, and long-lasting PONDs fall under the recommended terminology “perioperative neurocognitive disorders” (Evered et al., 2018). POND is defined by the presence of impaired memory, learning, and executive function after surgery (Migirov et al., 2021; Peden et al., 2021). POND without effective therapeutics and clear mechanisms is becoming a problem due to increased mortality, prolonged hospitalization, reliance on social transfer payments, and decreased quality of life (Eckenhoff et al., 2020; Peden et al., 2021).
The roles of ncRNAs in the development of POND are mentioned in our recent review elsewhere (He et al., 2021). Recent studies demonstrated that circ_089763 may be a crucial circRNA and function as a biomarker in the development of POND (Wang et al., 2019; Gao et al., 2020; Zhou et al., 2020). In serum samples from elderly patients with POND, the expression of circ_061570, circ_001145, and circ_101138 is increased (Gao et al., 2020). However, the mechanisms and effective therapeutics are unclear. ITSN1, a parent gene of circ_061570, plays an important role in early endocytic anomalies and the incidence of AD (Keating et al., 2006; Yu et al., 2008). Circ_001145 can sponge miR-1226-5p to the target gene Itsn1 in terms of circRNA–miRNA–mRNA axes. The network of circ_101138/miR-107/NEDD9 is predicted by Gao et al. (2020). Also, the upregulation of circ_009789 and circ_004229 may act as a sponge of miR-298-5p to upregulate the expression of Prkcb and Zbtb4 in the hippocampus of aging mice. Here, PKC signaling pathway, neural cell apoptosis, and glycolipid metabolism pathway are involved in the development of working memory dysfunction after surgery (Zhang M. X. et al., 2022).
Additionally, circ_101138 could regulate miR-376a/b-3p targeting HAS2 (Gao et al., 2020), which was associated with the pathogenesis of neuropathologic changes (Reed et al., 2019) and tau protein in AD-related neurocognitive dysfunction (Li et al., 2017). Additionally, circ_101138 could regulate miR-107, which was downregulated and a marker of the neurodegenerative process in AD concerning the Aβ metabolism and the inordinate cell cycle (Prendecki et al., 2019). However, the downregulation of miR-107 exerts the upregulation of SYK and worsens spatial memory in AD mice by activating the NF-κB signaling pathway (Hu et al., 2019). Here, circ_101138/miR-107/Syk might be another network of circRNA–miRNA–mRNA in the development of both POND and AD. A network of circ_101138/miR-107/Syk may explain the changes of POND in AD.
In another cohort study on geriatrics with no previous diagnosis of dementia, the level of Aβ1-42 in cerebral spinal fluid was the strongest independent predictor of postoperative delirium (included in PONDs) after elective arthroplasty in an aging population (Cunningham et al., 2019). Aβ is one of the key molecules involved in neurodegenerative diseases, and its degradation is partially regulated by the aforementioned networks of ciRS-7/miR-7a/Uchl1 and ciRS-7/miR-7a/Ubea2 (Zhao et al., 2016; Shi et al., 2017). As mentioned above, circHDAC9/miR-138/Sirt1 was involved in AD (Lu et al., 2019), while a decrease in Sirt1 was associated with improved postoperative cognition after cardiac surgery (Shi et al., 2020). In addition, circRNAs were engaged against POND by dexmedetomidine (Cao et al., 2020). Thus, the potential and protective roles of the circRNA–miRNA–mRNA axes would be studied in the future.
Conclusions and perspectives
The crosstalk between circRNA, miRNA, and mRNA (or proteins) through one or more circRNA–miRNA–mRNA networks indicates the complicated and dynamic mechanisms of brain cognitive disorders including AD (Zhao et al., 2016; Lu et al., 2019; Yang et al., 2019; Zhu et al., 2020; Li et al., 2022; Pan et al., 2022; Xu X. et al., 2022), PD (Kumar et al., 2018; Feng et al., 2020; Wang et al., 2021; Liu et al., 2022; Zhang et al., 2022), TBI (Chen et al., 2019; Li H. et al., 2020; Huang X. J. et al., 2022; Zheng et al., 2022), stroke (Bai et al., 2018; Han et al., 2018; Zhou et al., 2021; Guo et al., 2022; Huang et al., 2022; Xu T. et al., 2022; Yang H. et al., 2022; Yang J. et al., 2022), and POND (Gao et al., 2020) (Table 1). In summary, circRNAs act as sponging-like roles in transcription and posttranscription in the novel regulation processes of gene expression. However, none of the aforementioned studies were able to clearly determine the exact role of circRNA–miRNA–mRNA axes in the pathogenesis and development of brain disorders with cognitive dysfunction or impairment (Figure 2).
Table 1
| Diseases/ conditions | circRNAs | Sources (species, tissue, cells) | Trend | Roles | Functions | References |
|---|---|---|---|---|---|---|
| AD | ciRs-7 | Temporal lobe and hippocampal CA1 in 6 AD patients | Down | Promotor | ciRs-7↓ → miR-7↑ → UBEA2↓ → Aβ and senile plaque deposits↑ | (Zhao et al., 2016) |
| AD | circHDAC9 | Patients (5 males, 2 females); male APP/PS1 transgenic mice | Down | Suppressor | circHDAC9↓ → miR-138↑ → Sirt1↓ → Aβ↑ | (Lu et al., 2019) |
| AD | circ_0000950 | PC12 cells; rat cerebral cortex neurons | Down | Promotor | circ_0000950↑ → miR-103↓ → PTGS2↑ → neurite outgrowth↓, inflammatory cytokines (IL-1β, IL-6, and TNF-α)↑ → neuron apoptosis↑ | (Yang et al., 2019) |
| AD | circ_0001588 | Male Wistar rats; Neuro-2a cell line | Down | Suppressor | circ_0001588↓ → miR-211-5p↑ → Sirt1↓ → Nrf2/HO-1↓ → oxidative stress↑ → nerve cell death↑ | (Zhu et al., 2020) |
| AD | AXL | SK-N-SH and SK-SY5Y cells | Up | Promotor | AXL↑ → miR-328↓ → BACE1↑ → neuron injury↑ | (Li et al., 2022) |
| AD | circ_0003611 | SK-N-SH cells | Up | Promotor | circ_0003611↑ → miR-885-5p↓ → Kremen1↑ → Aβ-induced neuronal injury↑ | (Pan et al., 2022) |
| AD | circ_0005835 | Thirty AD patients; SH-SY5Y and BV2 cells | Up | Promotor | circ_0005835↓ → miR-576-3p↑ → neuroinflammation ↓, b-III Tubulin expression↑ | (Xu X. et al., 2022) |
| PD | cirzip2 | C. elegans Bristol strain N2 and NL5901 strain | Down | Promotor | cirzip2↓ → miR-60-3p↑ → α-syn↓ → α-synuclein aggregation↓ | (Kumar et al., 2018) |
| PD | circDLGAP4 | MPTP-induced mouse; MPP-induced SH-SY5Y and MN9D cells | Down | Suppressor | circDLGAP4↓ → miR-134-5p↑ → CREB↓ → viability↓, apoptosis↑, mitochondrial damage↑, autophagy↓ → neuroprotection↓ | (Feng et al., 2020) |
| PD | circSAMD4A | MPTP-induced mouse; MPP-induced SH-SY5Y cells | Up | Promotor | circSAMD4A↑ → miR-29c-3p↓ → AMPK/mTOR↑ → apoptosis and autophagy of dopaminergic neurons↑ | (Wang et al., 2021) |
| PD | circPank1 | Mice; MN9D cells | Up | Promotor | circPank1↑ → miR-7a-5p↓ → α-syn ↑ → dopaminergic neuron neurodegeneration↑ | (Liu et al., 2022) |
| PD | circ_0004381 | MPP-induced SK-N-SH cells | Up | Promotor | circ_0004381↑ → miR-185-5p↓ → RAC1↑ → inflammatory response↑, oxidative stress↑ → cell viability↓, apoptosis↑ | (Zhang et al., 2022) |
| TBI | chr8_87859283-87904548 | C57BL/6 mice | Up | Promotor | chr8_87859283-87904548↑ → let-7a-5p↓ → CXCR2↑ → neurological function↓ | (Chen et al., 2019) |
| TBI | circHtra1 | Hippocampus of rat | Up | Promotor | circHtra1↑ → miR-3960↓ → GRB10↑ → cell proliferation↓,apoptosis↑, NK cell infiltration↓ → neuronal deficits↑ | (Zheng et al., 2022) |
| TBI | circ_009194 | Hippocampus of rat | Up | Promotor | circ_009194↑ → miR-145-3p↓ → Sp1/Nav1.3↑ → neurological impairment↑, mNSS↑ | (Huang X. J. et al., 2022) |
| TBI | circLrp1b | Hippocampus of rat | Up | Promotor | circLrp1b↑ → miR-27a-3p↓ → Dram2↑ → autophagy↓, inflammation↑ → neurologic impairment↑ | (Li H. et al., 2020) |
| Stroke | circDLGAP4 | Patients (13 females, 13 males); mice | Down | Suppressor | circDLGAP4↓ → miR-143↑ → Hectd1↓ → infarct areas↑, BBB damage↑ → neurological deficits↑ | (Bai et al., 2018) |
| Stroke | Hectd1 | Plasma from AIS patients; tMCAO mice | Up | Promotor | circHectd1↑ → miR-142↓ → TIPARP↑ → infarct areas↑, astrocyte activation↑ → neuronal deficits↑ | (Han et al., 2018) |
| Stroke | Hectd1 | PC12 cells with OGD/R | Up | Promotor | cirHectd1↑ → let-7c-5p↓ → ROCK1↑ → apoptosis↑ | (Guo et al., 2022) |
| Stroke | circ_0025984 | Male SD rats with MCAO | Down | Suppressor | circRNA_0025984↓ → miR-143-3p↑ → TET1↓ → autophagy↑, apoptosis↑ | (Zhou et al., 2021) |
| Stroke | circ_0000831 | MCAO in mice | Down | Suppressor | circ_0000831↓ → miR-16-5p↑ → AdipoR2↓ → neuroinflammation↑, cell apoptosis↑ → neurological deficit↑ | (Huang et al., 2022) |
| Stroke | circSKA3 | Ischemic stroke patients (n = 220) | Up | Promotor | circSKA3↑ → miR-6796-5p↓ → MMP9↑ | (Xu T. et al., 2022) |
| Stroke | circRps5 | MCAO in mice | Down | Suppressor | circRps5↓ → miR-124-3p↑ → SIRT7↓ → M2 microglia/macrophage polarization↑ | (Yang H. et al., 2022) |
| Stroke | circUSP36 | Ischemic stroke patients; tMCAO mice | Down | Suppressor | circUSP36↓ → miR-139-3p↑ → SMAD3↓ → neurological deficit↑, motor function recovery↓ → brain injury↑ | (Yang J. et al., 2022) |
| POND | circ_001145 | Patients (n = 3) | Up | unknown | circ_001145↑ → miR-1226-5p → ITSN1* | (Gao et al., 2020) |
| POND | circ_101138 | Patients (n = 3) | Up | unknown | circ_101138↑ → miR-107 → NEDD9* | (Gao et al., 2020) |
| POND | circ_101138 | Patients (n = 3) | Up | unknown | circ_101138↑ → miR-376a/b-3p → HAS2* | (Gao et al., 2020) |
| POND | circ_009789 | Aging mice brain; Neuro-2a cells | Up | Promotor | circ_009789↑ → miR-298-5p↓ → Prkcb↑, Zbtb4↑ → cognition↓ | (Zhang M. X. et al., 2022) |
| POND | circ_004229 | Aging mice brain; Neuro-2a cells | Up | Promotor | circ_004229↑ → miR-298-5p↓ → Prkcb↑, Zbtb4↑ → cognition↓ | (Zhang M. X. et al., 2022) |
Circular RNAs (CircRNAs) in various brain cognitive disorders.
Expressions of circRNAs mentioned above were determined by real-time quantitative polymerase chain reaction (RT-PCR). *Predicted networks only.
AD, Alzheimer's disease; Aβ, β-amyloid; APP, β-amyloid precursor protein; BACE1, β-site APP-cleaving enzyme 1; NF-κB, nuclear factor kappa B; UBE2A, ubiquitin conjugating enzyme E2A; UCHL1, ubiquitin carboxyl-terminal hydrolase L1; Sirt1, silent information regulator 1; Nfr2, nuclear factor erythroid 2-related factor 2; HO-1, heme oxygenase-1; PTGS2, prostaglandin-endoperoxide synthase 2; PD, Parkinson's disease; TIPARP, TCDD inducible poly(ADP-ribose) polymerase; BBB, blood–brain barrier; tMCAO, transient middle cerebral artery occlusion; AIS, acute ischemic stroke; OGD/R, oxygen-glucose deprivation/reoxygenation; ROCK1, Rho-associated coiled-coil-containing protein kinase 1; MMP9, matrix metalloproteinase 9; TBI, traumatic brain injury; mNSS, modified Neurological Severity Score; ADSCs, adipose-derived stem cells; POND, postoperative neurocognitive disorder.
Figure 2

Regulatory networks of circRNA–miRNA–mRNA in various brain disorders. Changes in the regulatory networks of circRNA–miRNA–mRNA and potential signaling pathways are presented.
Different circRNAs sponge different miRNAs under various brain disorders (Figure 2). Meanwhile, the same circDLGAP4 can be involved in sponging different miRNAs, such as miR-143 in stroke (Bai et al., 2018) and miR-134-5p in PD (Feng et al., 2020). As it indicates that similar circRNA sponging different miRNAs may occur in different diseases. However, in similar brain disorders or conditions, circHectd1 can sponge different miRNAs, including miR-133b, let-7c-5p, and miR-142 (Han et al., 2018; Dai et al., 2021; Guo et al., 2022), indicating that one disease may embrace different pathways under different conditions. However, how should we check and determine which is the best pathway (Gao et al., 2020)?
The aforementioned studies on the circRNA–miRNA–mRNA network suggest that circRNAs as endogenous RNAs (ceRNAs) play important roles in discovering the pathogenesis and development of brain disorders in the future. Recently, some studies indicate that a subset of circRNAs has been considered as codes for proteins (Ma et al., 2020; Sinha et al., 2021). However, the available evidence shows that circRNA translation is not an efficient event. Herein, many more studies on circRNA–miRNA–mRNA networks are needed to update and expand our knowledge about increasing effective strategies to protect individuals from these brain disorders.
Funding
This work was supported by the Chuncheng Youth Top-notch Talent Support Program (2020), the Health and Family Planning Commission of Yunnan province (H-2017047), and partially by the National Natural Science Foundation of China (81860208).
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
Conceptualization, writing—original draft, and funding acquisition: LH. Formal analysis: LH, FZ, and YZ. Writing—review and editing: LH and ML. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis, contributed to the article, and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
BaiY.ZhangY.HanB.YangL.ChenX.HuangR.et al. (2018). Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. J. Neurosci.38, 32–50. 10.1523/jneurosci.1348-17.2017
2
BazanH. A.HatfieldS. A.BrugA.BrooksA. J.LightellD. J.Jr.WoodsT. C. (2017). Carotid plaque rupture is accompanied by an increase in the ratio of serum circR-284 to miR-221 levels. Circ. Cardiovasc. Genet.10, e001720. 10.1161/circgenetics.117.001720
3
CaoC.DengF.HuY. (2020). Dexmedetomidine alleviates postoperative cognitive dysfunction through circular RNA in aged rats. Biotechnology10, 176. 10.1007/s13205-020-2163-0
4
ChenY.YaoL.TangY.JhongJ. H.WanJ.ChangJ.et al. (2022). CircNet 2.0: an updated database for exploring circular RNA regulatory networks in cancers. Nucleic Acids Res.50, D93–d101. 10.1093/nar/gkab1036
5
ChenZ.WangH.ZhongJ.YangJ.DarwazehR.TianX.et al. (2019). Significant changes in circular RNA in the mouse cerebral cortex around an injury site after traumatic brain injury. Exp. Neurol.313, 37–48. 10.1016/j.expneurol.2018.12.003
6
ChoiD. C.ChaeY. J.KabariaS.ChaudhuriA. D.JainM. R.LiH.et al. (2014). MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. J. Neurosci.34, 12725–12737. 10.1523/jneurosci.0985-14.2014
7
Collaborators GDH (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet390, 1260–1344. 10.1016/s0140-6736(17)32130-x
8
CunninghamE. L.McGuinnessB.McAuleyD. F.ToombsJ.MawhinneyT.O'BrienS.et al. (2019). CSF beta-amyloid 1-42 concentration predicts delirium following elective arthroplasty surgery in an observational cohort study. Ann. Surg.269, 1200–1205. 10.1097/sla.0000000000002684
9
DaiQ.MaY.XuZ.ZhangL.YangH.LiuQ.et al. (2021). Downregulation of circular RNA HECTD1 induces neuroprotection against ischemic stroke through the microRNA-133b/TRAF3 pathway. Life Sci.264, 118626. 10.1016/j.lfs.2020.118626
10
D'AncaM.BuccellatoF. R.FenoglioC.GalimbertiD. (2022). Circular RNAs: emblematic players of neurogenesis and neurodegeneration. Int. J. Mol. Sci.23, 4134. 10.3390/ijms23084134
11
DongR.MaX. K.LiG. W.YangL. (2018). CIRCpedia v2: an updated database for comprehensive circular RNA annotation and expression comparison. Genom. Proteom. Bioinform.16, 226–233. 10.1016/j.gpb.2018.08.001
12
EckenhoffR. G.MazeM.XieZ.CulleyD. J.GoodlinS. J.ZuoZ.et al. (2020). Perioperative neurocognitive disorder: state of the preclinical science. Anesthesiology132, 55–68. 10.1097/aln.0000000000002956
13
ErrichelliL.Dini ModiglianiS.LaneveP.ColantoniA.LegniniI.CapautoD.et al. (2017). FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat. Commun.8, 14741. 10.1038/ncomms14741
14
EveredL.SilbertB.KnopmanD. S.ScottD. A.DeKoskyS. T.RasmussenL. S.et al. (2018). Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery−2018. Anesthesiology129, 872–879. 10.1097/aln.0000000000002334
15
FengZ.ZhangL.WangS.HongQ. (2020). Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway in Parkinson's disease. Biochem. Biophys. Res. Commun.522, 388–394. 10.1016/j.bbrc.2019.11.102
16
GaoR.ChenC.ZhaoQ.LiM.WangQ.ZhouL.et al. (2020). Identification of the potential key circular RNAs in elderly patients with postoperative cognitive dysfunction. Front. Aging Neurosci.12, 165. 10.3389/fnagi.2020.00165
17
GuoQ.GuoT.SunY.ChenT. (2022). Circ_HECTD1 regulates cerebral ischemia injury via mechanisms involving the regulation of let-7c-5p/ROCK1 axis. Neuroreport33, 13–22. 10.1097/wnr.0000000000001743
18
HallJ. M.LewisS. J. G. (2019). Neural correlates of cognitive impairment in parkinson's disease: a review of structural MRI findings. Int. Rev. Neurobiol.144, 1–28. 10.1016/bs.irn.2018.09.009
19
HanB.ZhangY.ZhangY.BaiY.ChenX.HuangR.et al. (2018). Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy14, 1164–1184. 10.1080/15548627.2018.1458173
20
HansenT. B.JensenT. I.ClausenB. H.BramsenJ. B.FinsenB.DamgaardC. K.et al. (2013). Natural RNA circles function as efficient microRNA sponges. Nature495, 384–388. 10.1038/nature11993
21
HeL.ZhangF.ZhuY.LuM. (2021). Noncoding RNAs: novel insights into postoperative neurocognitive disorders. ACS Chem. Neurosci.12, 1480–1486. 10.1021/acschemneuro.1c00148
22
HosakaT.YamashitaT.TamaokaA.KwakS. (2019). Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases. Int. J. Mol. Sci.20, 3148. 10.3390/ijms20133148
23
HuW.WenL.CaoF.WangY. (2019). Down-regulation of MIR-107 worsen spatial memory by suppressing SYK expression and inactivating NF-?B signaling pathway. Curr. Alzheimer Res.16, 135–145. 10.2174/1567205016666181212154347
24
HuangR.ZhangW.LiW.GaoY.ZhengD.BiG. (2022). Overexpressing circ_0000831 is sufficient to inhibit neuroinflammation and vertigo in cerebral ischemia through a miR-16-5p-dependent mechanism. Exp. Neurol.353, 114047. 10.1016/j.expneurol.2022.114047
25
HuangX. J.SuG. J.WuC. W.ShaX. S.ZouJ. F.LiuX. S.et al. (2022). Knockdown of rno_circRNA_009194 improves outcomes in traumatic brain injury rats through inhibiting voltage-gated sodium channel Nav1.3. J. Neurotrauma39, 196–210. 10.1089/neu.2020.7520
26
JiaE.ZhouY.LiuZ.WangL.OuyangT.PanM.et al. (2020). Transcriptomic profiling of circular RNA in different brain regions of Parkinson's disease in a mouse model. Int. J. Mol. Sci.21, 3006. 10.3390/ijms21083006
27
JunnE.LeeK. W.JeongB. S.ChanT. W.ImJ. Y.MouradianM. M. (2009). Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. USA.106, 13052–13057. 10.1073/pnas.0906277106
28
KeatingD. J.ChenC.PritchardM. A. (2006). Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1. Ageing Res. Rev.5, 388–401. 10.1016/j.arr.2005.11.001
29
KleavelandB.ShiC. Y.StefanoJ.BartelD. P. (2018). A network of noncoding regulatory RNAs acts in the mammalian brain. Cell174, 350-362.e317. 10.1016/j.cell.2018.05.022
30
KristensenL. S.AndersenM. S.StagstedL. V. W.EbbesenK. K.HansenT. B.KjemsJ. (2019). The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet.20, 675–691. 10.1038/s41576-019-0158-7
31
KumarL.ShamsuzzamaH. R.BaghelT.NazirA. (2017). Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases. Mol. Neurobiol.54, 7224–7234. 10.1007/s12035-016-0213-8
32
KumarL.ShamsuzzamaJ.adiyaP.HaqueR.ShuklaS.NazirA. (2018). Functional characterization of novel circular RNA molecule, circzip-2 and its synthesizing gene zip-2 in C. elegans model of Parkinson's disease. Mol Neurobiol55, 6914–6926. 10.1007/s12035-018-0903-5
33
LengB.SunH.ZhaoJ.LiuY.ShenT.LiuW.et al. (2020). Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients. Neurosci. Lett.723, 134866. 10.1016/j.neulet.2020.134866
34
LiH.LuC.YaoW.XuL.ZhouJ.ZhengB. (2020). Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury. Aging (Albany NY)12, 21687–21705. 10.18632/aging.103975
35
LiH. M.MaX. L.LiH. G. (2019). Intriguing circles: conflicts and controversies in circular RNA research. Wiley Interdiscip. Rev. RNA10, e1538. 10.1002/wrna.1538
36
LiY.HanX.FanH.SunJ.NiM.ZhangL.et al. (2022). Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease. Neurosci. Lett.776, 136531. 10.1016/j.neulet.2022.136531
37
LiY.LiZ. X.JinT.WangZ. Y.ZhaoP. (2017). Tau pathology promotes the reorganization of the extracellular matrix and inhibits the formation of perineuronal nets by regulating the expression and the distribution of hyaluronic acid synthases. J. Alzheimers. Dis.57, 395–409. 10.3233/jad-160804
38
LiY.LvZ.ZhangJ.MaQ.LiQ.SongL.et al. (2020). Profiling of differentially expressed circular RNAs in peripheral blood mononuclear cells from Alzheimer's disease patients. Metab. Brain Dis.35, 201–213. 10.1007/s11011-019-00497-y
39
LinS. P.YeS.LongY.FanY.MaoH. F.ChenM. T.et al. (2016). Circular RNA expression alterations are involved in OGD/R-induced neuron injury. Biochem. Biophys. Res. Commun.471, 52–56. 10.1016/j.bbrc.2016.01.183
40
LiuC.ZhangC.YangJ.GengX.DuH.JiX.et al. (2017). Screening circular RNA expression patterns following focal cerebral ischemia in mice. Oncotarget8, 86535–86547. 10.18632/oncotarget.21238
41
LiuQ.LiQ.ZhangR.WangH.LiY.LiuZ.et al. (2022). circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson's disease. Cell Death Dis.13, 477. 10.1038/s41419-022-04934-2
42
LuY.TanL.WangX. (2019). Circular HDAC9/microRNA-138/Sirtuin-1 pathway mediates synaptic and amyloid precursor protein processing deficits in Alzheimer's disease. Neurosci. Bull. 35, 877–888. 10.1007/s12264-019-00361-0
43
MaN.TieC.YuB.ZhangW.WanJ. (2020). Circular RNAs regulate its parental genes transcription in the AD mouse model using two methods of library construction. FASEB J.34, 10342–10356. 10.1096/fj.201903157R
44
MehtaS. L.PandiG.VemugantiR. (2017). Circular RNA expression profiles alter significantly in mouse brain after transient focal ischemia. Stroke48, 2541–2548. 10.1161/strokeaha.117.017469
45
MigirovA.ChaharP.MaheshwariK. (2021). Postoperative delirium and neurocognitive disorders. Curr. Opin. Crit. Care27, 686–693. 10.1097/mcc.0000000000000882
46
PanW.HuY.WangL.LiJ. (2022). Circ_0003611 acts as a miR-885-5p sponge to aggravate the amyloid-β-induced neuronal injury in Alzheimer's disease. Metab. Brain Dis.37, 961–971. 10.1007/s11011-022-00912-x
47
PedenC. J.MillerT. R.DeinerS. G.EckenhoffR. G.FleisherL. A. (2021). Improving perioperative brain health: an expert consensus review of key actions for the perioperative care team. Br. J. Anaesth.126, 423–432. 10.1016/j.bja.2020.10.037
48
PengX.JingP.ChenJ.XuL. (2019). The role of circular RNA HECTD1 expression in disease risk, disease severity, inflammation, and recurrence of acute ischemic stroke. J. Clin. Lab. Anal.33, e22954. 10.1002/jcla.22954
49
PrendeckiM.Florczak-WyspianskaJ.KowalskaM.IlkowskiJ.GrzelakT.BialasK.et al. (2019). APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer's disease. Folia Neuropathol.57, 106–116. 10.5114/fn.2019.84828
50
ReedM. J.DamodarasamyM.PathanJ. L.ChanC. K.SpiekermanC.WightT. N.et al. (2019). Increased hyaluronan and TSG-6 in association with neuropathologic changes of Alzheimer's disease. J. Alzheimers. Dis.67, 91–102. 10.3233/jad-180797
51
SalimU.KumarA.KulshreshthaR.VivekanandanP. (2022). Biogenesis, characterization, and functions of mirtrons. Wiley Interdiscip. Rev. RNA13, e1680. 10.1002/wrna.1680
52
SalmenaL.PolisenoL.TayY.KatsL.PandolfiP. P. (2011). A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?Cell146, 353–358. 10.1016/j.cell.2011.07.014
53
ShiJ.ZouX.JiangK.WangF. (2020). SIRT1 mediates improvement of cardiac surgery-induced postoperative cognitive dysfunction via the TLR4/NF-κB pathway. World J. Biol. Psychiatry21, 757–765. 10.1080/15622975.2019.1656820
54
ShiZ.ChenT.YaoQ.ZhengL.ZhangZ.WangJ.et al. (2017). The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-kappaB-dependent manner. FEBS J.284, 1096–1109. 10.1111/febs.14045
55
SinhaT.PanigrahiC.DasD.Chandra PandaA. (2021). Circular RNA translation, a path to hidden proteome. Wiley Interdiscip Rev RNA2021:e1685. 10.1002/wrna.1685
56
WangM.SuP.LiuY.ZhangX.YanJ.AnX.et al. (2019). Abnormal expression of circRNA_089763 in the plasma exosomes of patients with post-operative cognitive dysfunction after coronary artery bypass grafting. Mol. Med. Rep.20, 2549–2562. 10.3892/mmr.2019.10521
57
WangW.LvR.ZhangJ.LiuY. (2021). circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK/mTOR pathway in Parkinson's disease. Mol. Med. Rep.24, 12179. 10.3892/mmr.2021.12179
58
WuW.PengY.ZhouJ.ZhangX.CaoL.LinW. J.et al. (2021). Identification of the potential gene regulatory networks and therapeutics in aged mice with postoperative neurocognitive disorder. Front. Neurosci.15, 689188. 10.3389/fnins.2021.689188
59
XieB. S.WangY. Q.LinY.ZhaoC. C.MaoQ.FengJ. F.et al. (2018). Circular RNA expression profiles alter significantly after traumatic brain injury in rats. J. Neurotrauma35, 1659–1666. 10.1089/neu.2017.5468
60
XuT.LiY.ZhuN.SuY.LiJ.KeK. (2022). circSKA3 acts as a sponge of miR-6796-5p to be associated with outcomes of ischemic stroke by regulating matrix metalloproteinase 9 expression. Eur. J. Neurol.29, 486–495. 10.1111/ene.15164
61
XuX.GuD.XuB.YangC.WangL. (2022). Circular RNA circ_0005835 promotes promoted neural stem cells proliferation and differentiate to neuron and inhibits inflammatory cytokines levels through miR-576-3p in Alzheimer's disease. Environ. Sci. Pollut. Res. Int.29, 35934–35943. 10.1007/s11356-021-17478-3
62
YangH.TuZ.YangD.HuM.ZhouL.LiQ.et al. (2022). Exosomes from hypoxic pre-treated ADSCs attenuate acute ischemic stroke-induced brain injury via delivery of circ-Rps5 and promote M2 microglia/macrophage polarization. Neurosci. Lett.769, 136389. 10.1016/j.neulet.2021.136389
63
YangH.WangH.ShangH.ChenX.YangS.QuY.et al. (2019). Circular RNA circ_0000950 promotes neuron apoptosis, suppresses neurite outgrowth and elevates inflammatory cytokines levels via directly sponging miR-103 in Alzheimer's disease. Cell Cycle18, 2197–2214. 10.1080/15384101.2019.1629773
64
YangJ.HeW.GuL.LongJ.ZhuL.ZhangR.et al. (2022). CircUSP36 attenuates ischemic stroke injury through the miR-139-3p/SMAD3/Bcl2 signal axis. Clin. Sci. (Lond)136, 953–971. 10.1042/cs20220157
65
YesharimL.MojbafanM.AbiriM. (2021). Hints from the cellular functions to the practical outlook of circular RNAs. Front. Genet.12, 679446. 10.3389/fgene.2021.679446
66
YuY.ChuP. Y.BowserD. N.KeatingD. J.DubachD.HarperI.et al. (2008). Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities. Hum. Mol. Genet.17, 3281–3290. 10.1093/hmg/ddn224
67
ZhangH.WangC.ZhangX. (2022). Circular RNA hsa_circ_0004381 promotes neuronal injury in Parkinson's disease cell model by miR-185-5p/RAC1 axis. Neurotox. Res. 40, 1007–1019. 10.1007/s12640-022-00525-3
68
ZhangM. X.LinJ. R.YangS. T.ZouJ.XueY.FengC. Z.et al. (2022). Characterization of circRNA-associated-ceRNA networks involved in the pathogenesis of postoperative cognitive dysfunction in aging mice. Front. Aging Neurosci.14, 727805. 10.3389/fnagi.2022.727805
69
ZhaoR. T.ZhouJ.DongX. L.BiC. W.JiangR. C.DongJ. F.et al. (2018). Circular ribonucleic acid expression alteration in exosomes from the brain extracellular space after traumatic brain injury in mice. J. Neurotrauma35, 2056–2066. 10.1089/neu.2017.5502
70
ZhaoY.AlexandrovP. N.JaberV.LukiwW. J. (2016). Deficiency in the ubiquitin conjugating enzyme UBE2A in Alzheimer's disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel) 7, 116. 10.3390/genes7120116
71
ZhengP.ShuL.RenD.KuangZ.ZhangY.WanJ. (2022). circHtra1/miR-3960/GRB10 axis promotes neuronal loss and immune deficiency in traumatic brain injury. Oxid. Med. Cell. Longev.2022, 3522492. 10.1155/2022/3522492
72
ZhouD.HuangZ.ZhuX.HongT.ZhaoY. (2021). Circular RNA 0025984 ameliorates ischemic stroke injury and protects astrocytes through miR-143-3p/TET1/ORP150 pathway. Mol. Neurobiol.58, 5937–5953. 10.1007/s12035-021-02486-8
73
ZhouH.LiF.YeW.WangM.ZhouX.FengJ.et al. (2020). Correlation between plasma circRNA-089763 and postoperative cognitive dysfunction in elderly patients undergoing non-cardiac surgery. Front. Behav. Neurosci.14, 587715. 10.3389/fnbeh.2020.587715
74
ZhuR.QiX.LiuC.WangD.LiL.LiuX.et al. (2020). The silent information regulator 1 pathway attenuates ROS-induced oxidative stress in Alzheimer's disease. J. Integr. Neurosci.19, 321–332. 10.31083/j.jin.2020.02.1151
75
ZhuS.ChoudhuryN. R.RooneyS.PhamN. T.KoszelaJ.KellyD.et al. (2021). RNA pull-down confocal nanoscanning (RP-CONA) detects quercetin as pri-miR-7/HuR interaction inhibitor that decreases α-synuclein levels. Nucleic Acids Res.49, 6456–6473. 10.1093/nar/gkab484
Summary
Keywords
circular RNAs, cognitive dysfunction, neurocognitive, network, ceRNA
Citation
He L, Zhang F, Zhu Y and Lu M (2022) A crosstalk between circular RNA, microRNA, and messenger RNA in the development of various brain cognitive disorders. Front. Mol. Neurosci. 15:960657. doi: 10.3389/fnmol.2022.960657
Received
03 June 2022
Accepted
28 July 2022
Published
18 October 2022
Volume
15 - 2022
Edited by
Nan Wu, University of Toronto, Canada
Reviewed by
Sema MISIR, Cumhuriyet University, Turkey; Qiwei Yang, Second Affiliated Hospital of Jilin University, China
Updates
Copyright
© 2022 He, Zhang, Zhu and Lu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Liang He hauliang@163.comMeilin Lu cc21316@163.com
This article was submitted to Molecular Signalling and Pathways, a section of the journal Frontiers in Molecular Neuroscience
†ORCID: Liang He orcid.org/0000-0001-7246-4072
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.